Intervacc AB (IVACC)

Currency in SEK
1.1980
-0.0060(-0.50%)
Closed·
IVACC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.19601.2460
52 wk Range
0.57201.4620
Key Statistics
Prev. Close
1.204
Open
1.246
Day's Range
1.196-1.246
52 wk Range
0.572-1.462
Volume
153.32K
Average Volume (3m)
620.13K
1-Year Change
2.5685%
Book Value / Share
0.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IVACC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
13/05/2026
EPS / Forecast
-0.06 / --
Revenue / Forecast
3.4M / 8.6M
EPS Revisions
Last 90 days

Compare IVACC to Peers and Sector

Metrics to compare
IVACC
Peers
Sector
Relationship
P/E Ratio
−4.6x−3.4x−0.5x
PEG Ratio
−0.070.040.00
Price/Book
1.6x3.8x2.6x
Price / LTM Sales
21.4x11.9x3.1x
Upside (Analyst Target)
75.3%110.2%55.1%
Fair Value Upside
Unlock0.0%7.2%Unlock

Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden. The company’s product pipeline includes Stangvac, a vaccine against equine strangles for horses; INV274, antigens for a vaccine against streptococcus suis for the treatment of weaned piglets; and INV412, a multi-component vaccine to protect against several bacteria which cause mastitis for treating cows. It also engages in marketing and distribution of veterinary products in the Nordic markets, which includes vaccines and pharmaceuticals for swine, horses, cattle, and sheep. The company was incorporated in 1983 and is based in Hägersten, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
14.40M4.22%17.33M
Other Institutional Investors
115.31M33.83%138.83M
Public Companies & Retail Investors
211.11M61.94%254.17M
Total
340.81M100.00%410.34M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
HealthCap IX Investments AB25.89%88,235,294105,706
Fourth Swedish National Pension Fund (AP4)2.37%8,074,0009,673

People Also Watch

77.15
APOTEA
+1.45%
10.20
FLATb
+2.93%
44.76
HTRO
+1.89%

FAQ

What Is the Intervacc (Stockholm: IVACC) Share Price Today?

The Intervacc stock price today is 1.1980 SEK.

What Stock Exchange Does Intervacc (IVACC) Trade On?

Intervacc is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Intervacc?

The stock symbol (also called a 'ticker') for Intervacc is "IVACC."

What Is the Current Intervacc Market Capitalisation?

As of today, Intervacc (Stockholm: IVACC) market cap is 408.2900M SEK.

What Is Intervacc's (IVACC) Earnings Per Share (TTM)?

The Intervacc EPS is currently -0.2577 (Trailing Twelve Months).

When Is the Next Intervacc Earnings Date?

Intervacc's next earnings report will be released on 20/08/2026.

Is IVACC a Buy or Sell From a Technical Analyst Perspective?

Based on today's Intervacc moving averages and other technical indicators, the daily buy/sell signal for IVACC stock is Neutral.

How Many Times Has Intervacc Stock Split?

Intervacc has split 1 times. (See the IVACC stock split history page for full effective split date and price information.)

How Many Employees Does Intervacc Have?

Intervacc has 16 employees, based on their latest Companies House report.

What is the current trading status of Intervacc (Stockholm: IVACC)?

As of 20/05/2026, Intervacc (IVACC) is trading at a share price of 1.1980 SEK, with a previous close of 1.2040 SEK. The stock has fluctuated within a day range of 1.1960 SEK to 1.2460 SEK, while its 52-week range spans from 0.5720 SEK to 1.4620 SEK.

What Is Intervacc (IVACC) Price Target According to Analysts?

The average 12-month price target for Intervacc is 2.1000 SEK, with a high estimate of 2.1 SEK and a low estimate of 2.1 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +75.29% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.